Balasa Dinverno & Foltz LLC Bio Rad Laboratories, Inc. Transaction History

Balasa Dinverno & Foltz LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$463.67 - $597.16 $185,931 - $239,461	-401 Reduced 42.3%	547 $271,000
Q1 2022 Apr 25, 2022	SELL	$524.57 - $735.42 $171,009 - $239,746	-326 Reduced 25.59%	948 $534,000
Q4 2021 Jan 26, 2022	BUY	$708.84 - $794.68 $163,033 - $182,776	230 Added 22.03%	1,274 $963,000
Q3 2021 Oct 26, 2021	BUY	$657.71 - $825.77 $31,570 - $39,636	48 Added 4.82%	1,044 $779,000
Q2 2021 Jul 23, 2021	SELL	$576.64 - $649.04 $39,788 - $44,783	-69 Reduced 6.48%	996 $642,000
Q1 2021 Apr 29, 2021	BUY	$547.01 - $662.35 $20,786 - $25,169	38 Added 3.7%	1,065 $608,000
Q4 2020 Jan 26, 2021	BUY	$510.68 - $643.45 $80,687 - $101,665	158 Added 18.18%	1,027 $599,000
Q3 2020 Nov 10, 2020	BUY	$454.43 - $535.6 $93,158 - $109,798	205 Added 30.87%	869 $448,000
Q2 2020 Aug 07, 2020	BUY	$334.87 - $493.06 $222,353 - $327,391	664 New	664 $300,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.